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wileyonlinelibrary.com/journal/gps348Objectives: Hearing, vision, and cognitive impairment commonly co‐occur in older
adults. Improving sensory function may positively impact outcomes in people with
dementia (PwD). We developed a “sensory intervention” (SI) to support hearing and
vision in PwD. Here, we report the findings of an international open‐label field trial,
and nested case series, to explore the impact of the SI on dementia‐related outcomes.
Methods: This was a home‐based trial conducted in France, England, and Cyprus.
Participants were people with mild‐to‐moderate dementia and hearing and/or vision
impairment (n = 19) and their study partners (unpaid carers; n = 19). The “basic” SI
included a hearing and vision assessment and provision of glasses and/or hearing aids.
A subsample received the “extended” SI with additional weekly visits from a sensory
support therapist (SST). Exploratory analyses of dementia‐related, health utility and
resource utilisation outcomes were performed.
Results: Quality of life (QoL) and sensory functional ability improved. Change in
QoL exceeded the threshold for a minimum clinically important difference. There
was a modest improvement (in absolute terms) post intervention in behavioural dis-
turbance, self‐efficacy, and relationship satisfaction. Study partner time assisting
instrumental activities of daily living (iADL) and supervision decreased by about 22
and 38 hours per month, respectively, although time for personal ADL support
increased. Qualitative data supported effectiveness of the intervention: PwD were
more socially engaged, less isolated, less dependent on study partners, and had
improved functional ability and communication.
Conclusions: These findings support the need for a definitive randomised con-
trolled trial (RCT) to evaluate the effectiveness of the intervention.- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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impairment1 | INTRODUCTION
Hearing and vision impairments are more common in people with
dementia (PwD) than in those who are cognitively healthy.1,2 Such
impairments negatively affect a range of dementia‐related outcomes,
including quality of life (QoL), behaviour, and cognition, as well as
imposing an added burden on health, social, and informal care.3-6
There is some evidence that correcting vision and hearing impair-
ments with glasses and hearing aids, respectively, may improve
outcomes,7 but in PwD, adherence is often low.8 Thus, correcting
the sensory impairment alone may be insufficient and multifaceted
interventions, including adherence support and communication
training, may be needed. To address this, we developed a “sensory
intervention” (SI) comprising assessment and management of sensory
deficits, support with adherence and maintenance of devices, com-
munication training, sensory enhancement of the home environment,
and signposting to additional support services.5
The SI was developed, using an intervention mapping process, in
alignment with the theoretical framework of the evidence‐based
model of the Behavioural Change Wheel, particularly, the COM‐B
component.9 According to this model, key areas to be addressed to
effect behavioural change (“B”) include capability (“C”) or the individ-
ual's psychological and physical capacity to engage in the activity con-
cerned; opportunity (“O”) or all the factors that lie outside the
individual that make the living better with dementia possible; and
motivation (“M”) or the brain processes that direct goals and decision
making. Each component of the SI corresponded with one or more
of the COM‐B elements, as outlined in detail previously.5
A handful of interventions aimed at improving hearing or vision
impairment already exist, however, they either do not address the
problem of combined hearing and vision impairment or are not aimed
at PwD.7 Importantly, to be effective, interventions for sensory reme-
diation should address the specific needs of each individual, arguing
for highly tailored interventions rather than “off the shelf” or more
generic approaches.2,6,10
The SENSE‐Cog Field Trial was a key step in the iterative develop-
ment of the SI, and followed the guidance from the UK's Medical
Research Council on the development of complex interventions.11
Our aimwas to inform the design and conduct of a subsequent full‐scale
randomised controlled trial (RCT) to evaluate the effectiveness of SI ondementia‐related outcomes. Our field trial had two objectives (a) to
evaluate the feasibility, acceptability, and tolerability of the study proce-
dures and new intervention (reported separately)12 and (b) to explore a
signal of effectiveness and identify key drivers of resource use (for a
cost‐effectiveness evaluation) of this type of intervention (reported
here). The full‐scale RCT opened to recruitment in Spring 20185,13 in
five European sites: Athens, Dublin, Manchester, Nice, and Nicosia.2 | METHODS
2.1 | Study design and participants
This was a single‐arm, open‐label field study including 19 dyads (PwD
and their study partner). Study partners were family members or close
friends who knew the PwD well and had a role as an unpaid carer,
supporting the PwD with activities of daily living. They were coresi-
dent or in regular contact (at least twice per week) with the PwD.
Study sites were Bordeaux, France (site B), Manchester, United King-
dom (site M), and Nicosia, Cyprus (site N). All participant dyads
received the basic form of the SI. A subset of four dyads in site M
received an extended version, a multipart intervention comprising the
basic SI plus a package of support from a “sensory support therapist”
(SST). The SST delivered the intervention to both the PwD and their
study partner. We conducted semistructured interviews with a sub-
sample at sites M and N who received either the basic (n = 8) or
extended (n = 2) SI. We also include a nested case series of a purpo-
sive sample of four dyads who received the extended SI.
We recruited participants from memory assessment clinics or
through dementia research registries. Inclusion and exclusion criteria
are outlined inTable 1 and included older adults with a formal diagnosis
of a common form of dementia (Alzheimer disease, vascular dementia,
or mixed dementia) who also had adult‐acquired mild‐to‐moderate
hearing and/or vison impairment (see Table 1 for detailed criteria for
“impairment”). We excluded those with unstable medical or psychiatric
conditions or congenital sensory impairments. The study received
favourable ethical opinion at all sites, as per local requirements.
We have detailed participant characteristics in Table 2. Briefly,
PwD were above age 62 years, and study partners were above age
42. Of the PwD, 42% (n = 8) had hearing impairment only; 58%
Key points
• Hearing, vision, and cognitive impairment commonly co‐
LEROI ET AL.350(n = 11) had both vision and hearing impairment; and none had vision
impairment alone. There was an equal proportion of PwD due to
Alzheimer disease and vascular dementia; and one individual had
“mixed” dementia.occur in older adults and improvement in sensory
function may positively impact outcomes in people with
dementia (PwD).
• A sensory intervention (SI), involving both hearing and
vision support, was developed for PwD, with a view to
improve quality of life.
• Findings support the need for a full‐scale randomised
controlled trial to evaluate the effectiveness of hearing
and vision support in PwD and their care partners.2.2 | Description of the intervention
The basic SI involved a detailed vision and/or hearing assessment (home
or clinic based), followed by prescription and fitting of lenses or hearing
aids, as indicated by the assessment. The sensory assessmentswere car-
ried out by audiologists and/or optometrists in a manner suitable to
people with cognitive impairment, including allowing more time for
the assessment, clear explanations of each step andwritten information
regarding the procedures and devices prescribed. Hearing aids were
“behind the ear”Muse Mini BTE i2400 (Starkey HearingTechnologies),
and lenses were provided by Essilor International according to individ-
ual visual needs. This was followed by basic advice in using and
maintaining the sensory devices that did not extend beyond the fitting
visit. The extended SI (fully described in Regan et al14) comprised addi-
tional components: (a) individualised adherence support, comprising
repeated visits for detailed assessment and advice regarding the use
and maintenance of the devices; (b) communication training with the
study partner; (c) referral to health and social care services to address
comorbid problems; (d) supplementary aids to enhance sensory func-
tion in the homeenvironment (ie, glasses straps, hearing aid clips, special
lighting, and ambient noise management); and (e) support for social
inclusion through hobbies, interest, and social groups.
2.3 | Study procedures
The study protocol is detailed in‐depth elsewhere and is also outlined
in a flow diagram of study procedures in Chart S1.14 Briefly, after
informed consent, we screened PwD for sensory and cognitive impair-
ment, followed by a baseline assessment of feasibility and outcome
measures. We then delivered the basic SI for up to four visits (over
4 weeks) at all three sites. At site M, we offered the extended SI for
up to 12 visits (over 8 weeks) to a purposive subset of participants
with different combinations of hearing and/or vision impairments.
The basic SI offered to all dyads was to ascertain key feasibility
aspects of the intervention and to assess the dyads kept diaries of
each visit, and the SST kept a log book detailing visits and dyad
responses. Outcomes were assessed 1 week after the final interven-
tion visit, and in a purposive subset of 10 dyads (five dyads at each
of sites M and N) semistructured interviews were conducted to
explore how dyads received the intervention and perceived its effec-
tiveness. The details of the qualitative methods applied, including the
use and development the topic guide for the interviews, is outlined
in detail in the published protocol.13,14
2.4 | Battery of effectiveness measures
As outlined inTable S2, for the PwD, we assessed cognition, behaviour,
mental well‐being, and self‐efficacy. For the study partner, we includedmeasures of physical and mental well‐being and caregiver burden. We
assessed relationship satisfaction and QoL in both dyad members. To
calculate the health status of the PwD for the economic analysis, we col-
lected generic (EQ‐5D‐5L)22 and dementia‐specific (DEM‐QoL)23 mea-
sures (self‐rated and proxy rated),24 and the Resource Utilisation in
Dementia (RUD) Lite,25 to capture resource use of the PwD (during
the month prior to baseline, and at follow‐up, since baseline).
In those who received the extended SI, we explored additional out-
comes using (a) goal setting and (b) participant diaries and SST logbooks.
Goal setting: Goal setting in this study was used as a flexible, yet
validated method of capturing meaningful, robust outcomes. A maxi-
mum of three goals were set relating to components of the interven-
tion, using the Bangor Goal Setting Inventory (BGSI).26 Following
goal identification, the SST explored facilitators and barriers to goal
attainment and supported progress through introducing skills
and strategies. The PwD and study partner individually rated perfor-
mance on introduction of the goal and at review on a 10‐point scale
(1 = “cannot do successfully” to 10 = “can do successfully”). The SST
rated goal attainment at review on a 5‐point scale (0%, 25%, 50%,
75%, or 100%).
Participant diaries and SST logbooks: These included free‐text spaces
for feedback, and Likert‐style ratings of the SI, on (a) level of engage-
ment of the PwD (study partner and SST rated: 1 = strongly disagree
to 5 = strongly agree) and (b) perceived helpfulness (dyad rated: 1 =
“not at all helpful” to 5 = “very helpful”). The SST logbook also included
measures of the PwD's hearing aid use skill and ability (Hearing Aid Skills
and Knowledge Questionnaire; HASK)27 and glasses use skill and ability
(a bespoke Glasses/Vision Skills and KnowledgeTest).
3 | DATA ANALYSIS
3.1 | Quantitative analysis
As an initial exploration of a novel intervention, our goal was to
observe any signal of change across various outcome measures. We
examined the change between baseline (preintervention) and follow‐
up (post intervention) by summarising distributions of outcome mea-
sures with measures of central tendency (mean or median) and
TABLE 2 Summary of participant demographics and clinical characteristics
Participant Demographic and Clinical Characteristics at Baseline (n = 19
dyads)
PwD Age Median 76 y (IQR, 11; range 63‐88)
Male sex 63% (n = 12)
MoCA Mean 17.3 (SD 3.7; range 12‐23)
Duration of cognitive impairment Median 60 mo (IQR, 54; range 6‐120)
Dementia type Alzheimer disease (n = 9); vascular dementia (n = 9); mixed dementia (n = 1)
Hearing impairment only 42% (n = 8)
Vision impairment only None
Combined hearing and vision impairment 58% (n = 11)
Level of hearing impairment in those
screened positive
n = 12 detected the same number of tones in both ears out of 6 (2 tones = 1, 3 tones = 4, 4
tones = 5, 5 tones = 2);
n = 7 had scores of 3/2, 1/3, 1/3, 2/5, 3/5, 4/5, 4/5 for left and right ears, respectively
Level of visual impairment in those
screened positive
n = 9 had mild impairment (+0.2 to 0.5 LogMAR);
n = 2 had moderate impairment (+0.6 to 0.9 LogMAR) (ICD10 classification21)
Study partners Age Median 67 y (IQR, 13; range 43‐82)
Sex 68% (n = 13)
Coresident with participant with dementia 79% (n = 15)
Abbreviations: IQR, interquartile range; MoCA, Montreal Cognitive Assessment.18
TABLE 1 Summary of participant inclusion and exclusion criteria and characteristics
Participant Study Criteria
Detailed previously in Reganet al14
Inclusion Age ≥60 y
Domiciliary status Community based (living at home)
Cognitive impairment Formal clinical diagnosis of a common form of dementia (Alzheimer disease, vascular dementia or “mixed”
Alzheimer, and vascular dementia)a
Stage of cognitive function Early‐moderate stage dementia (as per the MoCA score of ≥12)
Hearing or vision
impairment or both
Screening positive for hearing impairment defined as bilateral hearing difficulty (ie, failure on a pure tone
hearing screening test (using the handheld HearCheck screening device15 in both ears—hearing >35 dB HL
over 1‐3 kHz and above in the better ear; the HearCheck screener provides a count of detected signals at or
above threshold levels for two frequencies (three levels per frequency) and gives the total number of tones
detected from 0‐6 for each ear. A participant was considered to have a “positive” screen with any score less
than 6 in both ears.
Screening positive for vision impairment defined as distance binocular visual acuity with current equipment
≤6/9.5 and >6/60 in Snellen metric (or ≥+0.2 logMAR [75 EDTRS Score] and <+1.0 logMAR [35 EDTRS
Score]) and visual field >10°; screened using the PEEK tool16 a smartphone‐based visual acuity check app
alongside the confrontation visual field test: “can you see my hands?.”
Capacity to consent to the
study
Assessed using the criteria for capacity defined by the UK's Mental Capacity Act (2005)17
Study partner An adult study partner familiar with and in regular contact with (at least twice a week) the participant with





Congenital hearing and/or vision impairments
General status Any unstable, acute physical or mental condition that would preclude participation in the study
Abbreviation: MoCA, Montreal Cognitive Assessment.18
aDiagnosed with dementia in accordance with ICD10 (10th revision of the International Statistical Classification of Diseases and Related Health Problems)
criteria because of the following conditions: Alzheimer disease (in accordance with NINCDS‐ADRDA19 criteria) or vascular dementia (in accordance with
NINDS‐AIREN20 criteria) or “mixed” dementia.
LEROI ET AL. 351variability (SD or interquartile range [IQR]). The small sample size pre-
cluded investigation of associations among outcomes. The covariates
of interest were not heavily skewed, and mean and medians were sim-
ilar; thus, we report mean values here.3.2 | Economic analysis
Our aim here was to test the performance of tools to measure health
status and the use of health and social care resources including informal
LEROI ET AL.352care in preparation for the economic evaluation of the full SENSE‐Cog
RCT. In the full RCT, we will quantify the incremental changes in costs
and benefits between the intervention and care as usual, from the
health care provider and societal perspectives. Here, our measure of
benefit for the primary analysis was health utility, derived from the
EQ‐5D‐5L and value set for England.28 Secondary analyses derived util-
ity values from the DEM‐QoL and respective value set for England.29
We also summarised utility values based on self‐rated and proxy‐rated
responses on both questionnaires and described the use of health and










HHIE‐S (only hearing impairment) 8.52 (8.08)
0 to 26
LV‐VFQ‐20 (only vision impairment) 2.54 (1.14)
0.86 to 4.22
SF‐12 PCS 45.74 (11.85)
23.36 to 56.82
SF‐12 MCS 49.38 (10.10)
35.12 to 60.70
SF‐12 Proxy PCS 42.02 (10.46)
21.23 to 55.50










Abbreviations: BADLS, Bristol Activities of Daily Living Scale32; DEM‐QoL(‐P), d
S, Hearing Handicap Inventory for the Elderly Screening tool34; LV‐VFQ‐20, Lo
score; NPI‐12, Neuropsychiatric Inventory 1236; PCS, physical component s
Survey.38
aFour participant dyads completed the baseline evaluations only, thus no post
intervention group withdrew due to the burden of study visits, and the remain
to deliver the intervention.
bMagnitude score = frequency × severity.
cn = 18 or 19, except for LV‐VFQ‐20 (n = 11).
dn = 15, except for LV‐VFQ‐20 (n = 10) and GSE (n = 14).3.3 | Qualitative analysis
The free‐text feedback of the participant diaries and SST logbooks, as
well as the postintervention semistructured interviews, were evalu-
ated according to summative content analysis methodology, a reliable
method of analysing of qualitative data using “coding units.”30,314 | RESULTS
Of the 19 participant dyads, eight each were from site M and site N,
and three were from site B. Site B did not complete outcome assess-





92.27 (11.14) 97.13 (9.69) 4.87 (9.93)
61 to 106 77 to 110 −15 to 28
101.73 (11.45) 99.20 (11.85) −2.53 (6.45)
85 to 121 79 to 120 −13 to 8
7.87 (7.95) 6.53 (3.96) −1.33 (6.53)
0 to 26 0 to 16 −10 to 8
2.65 (1.13) 3.45 (1.00) 0.80 (1.16)
0.86 to 4.22 1.59 to 4.79 −0.23 to 3.68
44.21 (12.48) 45.06 (11.01) 0.86 (6.47)
23.36 to 56.23 22.96 to 57.23 −13.12 to 10.65
50.02 (9.73) 50.88 (11.22) 0.86 (9.65)
35.12 to 60.70 22.12 to 68.41 −13.00 to 22.19
42.24 (10.44) 45.12 (10.21) 2.87 (9.19)
21.23 to 55.50 24.75 to 57.82 −12.90 to 18.2
51.12 (8.60) 50.44 (7.18) −0.68 (7.49)
35.38 to 62.28 37.81 to 58.19 −15.43 to 11.74
9.80 (9.10) 8.60 (7.96) −1.20 (11.42)
0 to 32 0 to 26 −28 to 20
2.76 (0.50) 2.89 (0.56) 0.13 (0.46)
2.1 to 3.7 2.1 to 4.0 −0.5 to 1.1
11.73 (7.99) 14.33 (7.93) 2.60 (3.33)
1 to 31 0 to 34 −5 to 8
29.13 (1.77) 29.60 (0.74) 0.47 (1.64)
25 to 30 28 to 30 −2 to 5
ementia quality of life (‐Proxy)23,29; GSE, Generalised Self‐Efficacy33; HHIE‐
w Vision Visual Functioning Questionnaire‐2035; MCS, mental component
core; RSS, Relationship Satisfaction Scale37; SF‐12, 12 Item Short Form
intervention data were obtained on them. One dyad within the extended
ing three dyads were lost to follow‐up due to lack of feasibility of the site
TABLE 4 Baseline and postintervention measurements for the study














3.08 (2.75) 3.62 (2.66) 0.54 (2.44)






27.20 (5.63) 28.00 (3.51) 0.80 (4.06)






13.53 (4.26) 13.87 (4.34) 0.33 (3.64)





7.53 (2.13) 7.93 (2.89) 0.40 (2.10)
4 to 15 4 to 12 4 to 13 −3 to 4
PHQ‐15 6.18
(4.52)
6.15 (3.85) 7.34 (5.08) 1.19 (3.59)
0 to 16 0 to 15 1 to 19.2 −3 to 11.2
RSS 23.63
(9.93)
27.36 (2.71) 26.64 (3.23) −0.71
(2.67)
1 to 30 21 to 30 18 to 30 −7 to 3
Abbreviations: FCRS, Family Care Giving Role Scale42; GDS‐15, Geriatric
Depression Scale 1543; PHQ‐15, Patient Health Questionnaire 15‐Items44;
RSS, Relationship Satisfaction Scale.37
aFour participant dyads completed the baseline evaluations only, thus no
postintervention data were obtained on them. One dyad within the
extended intervention group withdrew due to the burden of study visits,
and the remaining three dyads were lost to follow‐up due to lack of feasi-
bility of the site to deliver the intervention.
bn = 18, except for GDS‐15 and FCRS Resentment (n = 17) and RSS
(n = 19).
cn = 15, except for GDS‐15 (n = 13) and RSS (n = 14).
LEROI ET AL. 3534.1 | Effectiveness outcomes
Descriptive statistics of outcome variables are presented in Table 3.
The average difference on the DEM‐QoL,23 the main outcome for
the trial, post intervention was 4.87 points (a 4‐point improvement is
considered clinically important), indicating that PwD felt their QoL
had improved following the SI. All eight PwD from site M showed
improvement (between 3 and 28 points), whereas participant
responses from site N varied (two worsened, two no change, four
improved; range −15 to 8 points). The DEM‐QoL‐Proxy,39 rated by
the study partner on behalf of the PwD, showed an average decline
of 2.53 points, with 10 of the 15 study partners reporting a decline
post intervention, although this did not fall above threshold for a min-
imum clinically important difference, which may be as high as 6
points.40 In PwD, both hearing and vision functional ability improved
post intervention, as reflected by lower scores on the HHIE‐S34 and
higher scores on the LV‐VFQ‐2035 visual ability subscale.
There was a modest improvement, in absolute terms, post inter-
vention, on other outcomes for the PwD. There were minimal changes
on the PwD self‐rated physical and mental functioning component
scores and on the proxy‐rated mental component score but a small
increase in the PwD proxy‐rated physical functioning score post inter-
vention. Slight improvements were observed in informant‐rated neu-
ropsychiatric symptoms (on the NPI‐12)36 and general self‐efficacy
(on the GSE scale).33 Relationship satisfaction (RSS)37 at baseline
was rated as high by both PwD and study partners at baseline. For
the PwD, this improved following the intervention, but for the study
partner, this decreased slightly. Finally, functional ability in the PwD,
ascertained using the BADLS,32 decreased slightly following the inter-
vention (a 2.6‐point average score increase); however, this change did
not reach threshold for a minimum clinically important difference (at
least a 3.5‐point difference.)41
In study partners, as presented in Table 4, mean self‐rated depres-
sion using the GDS‐1545 reflected a low baseline level of depression
(<5), with minimal change post intervention. Caregiving, rated using
three subscales of the FCRS,42 showed minimal changes in levels of
caregiving‐related satisfaction, resentment, and anger from baseline
to post intervention. Finally, physical well‐being, rated using the 15‐
item PHQ‐15,44 ranged from 1 to 15 (on a 30‐point scale) at baseline,
and there was a small deterioration (an average of 1.1 points) post
intervention.4.2 | Health economic outcomes
Resource use and health utility are summarised in Table 5. Study
partners' average time spent assisting with personal activities of daily
living (ADL) increased by 17 h/mo; however, time spent assisting with
instrumental ADL decreased by 22 h/mo, and time spent supervising
declined by 39 h/mo. Proxy‐rated health utility was lower than self‐
rated utility according to both instruments (EQ‐5D‐5L and DEM‐
QoL). In contrast, self‐rated utility on the DEM‐QoL increased,
whereas proxy‐rated utility decreased.4.3 | Qualitative findings from semistructured
interviews
In Table S3, we have summarised the key themes from the
semistructured interviews, illustrated by exemplar quotes from partic-
ipants. These revealed positive effects of the intervention, including
applicability of the SI to everyday life. Key themes to emerge included
an improvement in communication skills within the dyad. For both
members of the dyad, knowledge, awareness, and understanding of
the nature and cause of the cognitive, behavioural, and functional
changes in the PwD improved, as well as the use and maintenance
of the devices. In a few cases, PwD took over the management of
their hearing aids independently. Another theme was the advantages
of a home‐based intervention with therapist support. This approach
made participants feel comfortable, enhanced adherence to using the
hearing aids and glasses, and fostered the view of the therapist as a
“friend.” These themes were supported and extended by the free‐text
comments in the participant diaries (Table S4).









Resource Utilisation in Dementia (RUD) Lite25
(at baseline: resource use in previous month; at follow‐up: resource use since baseline)
Number of caregivers in addition to primary caregiver 1.1 (1.2) 1.1 (1.3) 0.8 (1.2) −0.3 (1.0)
0 to 4 0 to 4 0 to 4 −2 to 2
Caregivers in paid employment 7/19 (37%) 5/14 (36%) 5/14 (36%) 0
Informal care time
Time spent assisting with PADL,d h/mo 29.6 (48.8) 37.5 (1.3) 54.2 (94.4) 16.7 (57.1)
0 to 3 0 to 145 0 to 300 −60 to 155
Time spent assisting with IADL,d h/mo 70.7 (79.3) 79.5 (90.4) 57.5 (52.5) −22.0 (97.7)
0 to 300 0 to 300 1 to 150 −295 to 90
Time spent supervising,d h/mo 61.9 (111.6) 81.9 (124.7) 43.2 (75.2) −38.7 (86.3)
0 to 360 0 to 210 −200 to 1100 to 360
Number of consultations with doctor, psychologist, physiotherapist, or other HCP 1.4 (1.2) 1.5 (1.1) 1.5 (1.6) 0.1 (1.6)
0 to 4 0 to 4 0 to 5 −3 to 3
Use of services, home help, district nurse visits, day care, or other social care services 3.2 (6.3) 3.5 (6.9) 3.0 (6.3) −0.5 (6.5)
0 to 20 0 to 20 0 to 20 −20 to 12
PwD's health utility, instrument derived from (EQ‐5D‐5L or DEM‐QoL) and assessor (self‐rated or proxy rated)
EQ‐5D‐5L generated utility (self‐rated) 0.83 (0.17) 0.82 (0.18) 0.82 (0.14) 0.00 (0.12)
0.5 to 1 0.6 to 1 −0.2 to 0.30.5 to 1
EQ‐5D‐5L generated utility (proxy rated) 0.77 (0.21) 0.80 (0.17) 0.82 (0.15) 0.03 (0.08)
0.5 to 1 0.6 to 1 ‐0.2 to 0.20.2 to 1
DEM‐QoL generated utility (self‐rated) 0.87 (0.10) 0.87 (0.11) 0.92 (0.07) 0.05 (0.10)
0.6 to 1 0.8 to 1 −0.1 to 0.30.6 to 1
DEM‐QoL generated utility (proxy rated) 0.82 (0.11) 0.81 (0.12) 0.79 (0.12) −0.02 (0.1)
0.5 to 0.9 0.5 to 0.9 −0.2 to 0.10.5 to 0.9
Abbreviations: DEM‐QoL, dementia quality of life23,29; EQ‐5D‐5L, EuroQol Five Dimensions Five Levels28; HCP, health care professional; iADL, instrumen-
tal activities of daily life; PADL, personal activities of daily life.
aFour participant dyads completed the baseline evaluations only, thus no postintervention data were obtained on them. One dyad within the extended
intervention group withdrew due to the burden of study visits, and the remaining three dyads were lost to follow‐up due to lack of feasibility of the site
to deliver the intervention;
bn = 19, except for DEM‐QoL generated utility proxy (n = 18).
cn = 14/15, except for EQ‐5D‐5L generated utility proxy (n = 16).
dHours/month derived from hours/day and days/month.
LEROI ET AL.3544.4 | Nested case series for the extended
intervention recipients
In Table S4, we describe in detail the four dyads who received the
extended SI.
4.4.1 | Description of cases and findings from the
extended SI
Three PwD completed the full intervention (cases 1 to 3; all received
hearing aids and one received glasses). One PwD (case 4) withdrew
after four visits due to anxiety, although he accepted hearing aids
and glasses, after which his study partner reported that hiscommunication improved. In the completing dyads, hearing aid skills
and knowledge improved with SST support. Adherence to hearing aids
was as prescribed (ie, waking hours) in three of the four PwD who
received the aids. The nonadherent participant (case 3) had problems
with the fit of the hearing aid and his use diminished over time.
4.4.2 | Goal setting outcomes
Dyads set between two to three goals around the following themes:
device use, device care, communication, function, and social inclu-
sions. Mean goal changes post intervention were all positive and
ranged from 2.7 to 4.2 points for PwD and 4.3 to 4.7 points for study
partners, on the 10‐point scale. Of the nine completed goals, nearly all
LEROI ET AL. 355(89%) were rated at least 75% attained by the SST, which we consid-
ered acceptable.4.4.3 | Participant diary and therapist logbooks
PwD mean diary ratings of “helpfulness” of the SI components indi-
cated moderately high (≥3 out of 5) “helpfulness.” Study partner diary
and SST log book mean ratings of PwD “initiative” both indicated a
range from “disagree” to “strongly agree.” Qualitative findings from
the dyad diaries and SST logbooks reported improved hearing function
with an overall positive impact of the SI, supporting the findings from
the semistructured interviews. For example, dyads reported notable
improvements in the PwD's performance of ADL and resumption of
previous activities, which they felt related to improved hearing. This,
in turn, lessened their dependence on their study partner through
increased confidence and independence. Study partners reported that
receiving the intervention led to improved communication and rela-
tionship quality for the dyad, and the PwD being able to follow multi-
ple strands of conversation and being more engaged with family life.
One study partner reported, “I feel like I've got him back.” PwD them-
selves reported feeling “more confident” and “vocally alive.” Partici-
pant dyads also described how hearing aids helped combat the social
isolation due to the combined cognitive‐sensory impairments, and fos-
tered a positive affect, which impacted positively on their relationship,
supporting the quantitative findings.5 | DISCUSSION
This is the second report of the SENSE‐Cog Field Trial detailing the
impact of a home‐based intervention of both hearing and/or vision
remediation in people living with dementia and their study partners.
In the first report, we detailed the feasibility of conducting such a
study in this population, as well as the acceptability and tolerability
of the intervention itself.12 Findings in that report have informed the
design and conduct or a larger, follow‐on RCT.13 Here, our exploratory
analysis has revealed that managing hearing and vision impairment in
PwD has a positive impact on a number of outcomes, including QoL,
self‐efficacy, and neuropsychiatric symptoms. For those receiving the
extended intervention with SST input, synthesis of qualitative, diary
and SST logbook findings clearly supported the intervention: PwD
were more socially engaged and less isolated and reported improve-
ments in functional ability and communication. They were less depen-
dent on study partners. Given the limitations of the sample size, it
appears that there is a good range of scores across all outcomes. There
was a mix of sizeable positive changes (mostly PwD), and some small
negative changes (mostly study partners), in individual scores post
intervention.
Our finding of a positive impact on health‐related QoL (HRQL) in
PwD is important; we have thus selected this as the primary outcome
for the follow‐on RCT, using the DEM‐QoL. Mean baseline DEM‐QoL
ratings of our study sample were similar to other studies of psychoso-
cial interventions for PwD,46,47 and the improvement noted wasreflected not only in the DEM‐QoL score but also in health utility
values derived from the DEM‐QoL, and the positive qualitative feed-
back on the intervention by both members of the dyads. Differences
in the DEM‐QoL change scores between sites may be due to cultural
factors, which will be explored in a detailed process analysis in the
follow‐on RCT. The specific positive findings on social isolation,
resumption of previous activities, and self‐efficacy rating further
underscore the favourable impact of the intervention on HRQL.
The improvement in functional ability found in the qualitative data
was interesting, considering BADLS ratings revealed a slight worsen-
ing of postintervention scores. However, we have interpreted the
quantitative outcomes in our study with caution since it was not
designed to evaluate effectiveness, and rating scale outcomes were
intended only to provide a proof of concept of the intervention to
inform a fully powered RCT. Importantly, the drop in number of care-
giving and supervision hours per month reinforced our finding of an
improvement in self‐efficacy in the PwD. The increase in personal care
provided may reflect the additional time spent supporting the PwD's
use of the sensory aids. Considering that informal care for PwD has
been valued at nearly £132 billion per year,48 improving sensory func-
tion in PwD potentially has the additional benefit of providing some
relief for their carers or families. Field testing the collection of data
required for an economic evaluation in the full RCT was an important
aspect of the study. The overall quality of the economic data was
good, with minimal missing data for completing dyads, and we have
gathered intelligence to guide data collection more precisely. For the
RCT, we will use country‐specific utility value sets for the EQ‐5D‐5L
and the DEM‐QoL where available at the time of analysis.
Limitations of our field trial include the nonblinded study design
and the small sample size. However, undertaking a feasibility study
such as this is a necessary step prior to conducting a RCT, and it gave
us the opportunity to make iterative changes to the study procedures
and invention. We have powered a full RCT of the SI to detect a dif-
ference of 4 points on the DEM‐QoL. Assuming that participants in
the “care as usual” comparison group do not improve post interven-
tion, a sample size of 354 dyads should detect any clinically important
effect of the intervention.
Finally, the strengths of our study include the comprehensiveness
of the intervention approach, the international reach, and the variety
of methods of ascertaining outcomes, which contributes to the emerg-
ing field of sensory support in people living with dementia.ACKNOWLEDGEMENTS
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